HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subatmospheric oxygen therapy complicating subcutaneous emphysema.

Abstract
An infant with hypoplastic left heart syndrome, excessive pulmonary blood flow, and tachypnea was placed on subatmospheric oxygen (supplemental nitrogen) to increase pulmonary vascular resistance and decrease pulmonary blood flow. His cardiorespiratory status stabilized without mechanical ventilation, but 2 weeks later he developed spontaneous subcutaneous emphysema. The emphysema worsened over approximately 1 month. During this time his left-to-right shunt gradually decreased, and he was weaned to room air. Even without the use of supplemental oxygen the emphysema resolved without complication, and the patient underwent successful orthotopic heart transplantation at 65 days of age.
AuthorsD A Dodd, J A Johns, W F Walsh
JournalPediatric cardiology (Pediatr Cardiol) 1998 Sep-Oct Vol. 19 Issue 5 Pg. 422-4 ISSN: 0172-0643 [Print] United States
PMID9703571 (Publication Type: Case Reports, Journal Article)
Topics
  • Humans
  • Hypoplastic Left Heart Syndrome (surgery)
  • Infant, Newborn
  • Male
  • Oxygen Inhalation Therapy (adverse effects)
  • Subcutaneous Emphysema (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: